The Food and Drug Administration says it is “rapidly” working toward issuing an emergency use authorization for the Moderna vaccine — the second Covid-19 vaccine for the US market — after its vaccine advisers voted to recommend it.
The Food and Drug Administration says it is “rapidly” working toward issuing an emergency use authorization for the Moderna vaccine — the second Covid-19 vaccine for the US market — after its vaccine advisers voted to recommend it.
